Recordati sets out three-year growth plan

7 May 2021 - Deborah Wilkes

Premium

Recordati plans to increase sales of its Procto-Glyvenol haemorrhoid treatment by more than a third by 2023 as part of a three-year plan which also includes developing new probiotic food supplements and acquisitions of OTC brands.

Click tags below for more information on topics:

Recordati

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: